PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 62 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,271,267 | -0.2% | 3,175,462 | +20.2% | 0.00% | – |
Q2 2023 | $5,281,942 | +2065.6% | 2,640,971 | +2173.9% | 0.00% | – |
Q1 2023 | $243,900 | +74.7% | 116,143 | +14.0% | 0.00% | – |
Q4 2022 | $139,594 | +35.5% | 101,893 | +3.2% | 0.00% | – |
Q3 2022 | $103,000 | -7.2% | 98,763 | -2.7% | 0.00% | – |
Q2 2022 | $111,000 | -4.3% | 101,553 | -6.9% | 0.00% | – |
Q1 2022 | $116,000 | +22.1% | 109,061 | -4.7% | 0.00% | – |
Q4 2021 | $95,000 | -40.3% | 114,398 | -4.3% | 0.00% | – |
Q3 2021 | $159,000 | -32.1% | 119,555 | -2.4% | 0.00% | – |
Q2 2021 | $234,000 | +3800.0% | 122,499 | +8835.0% | 0.00% | – |
Q1 2021 | $6,000 | -75.0% | 1,371 | -78.2% | 0.00% | – |
Q3 2020 | $24,000 | 0.0% | 6,284 | 0.0% | 0.00% | – |
Q2 2020 | $24,000 | – | 6,284 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spire Wealth Management | 148,800 | $158,000 | 0.00% |
MEITAV INVESTMENT HOUSE LTD | 244,332 | $257,000 | 0.00% |
Phoenix Holdings Ltd. | 244,113 | $259,000 | 0.00% |
IHT Wealth Management, LLC | 24,000 | $25,000 | 0.00% |
Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
Virtu Financial LLC | 15,199 | $16,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 41,574 | $44,000 | 0.00% |
Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,790 | $31,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5,153 | $5,000 | 0.00% |